Search filters

List of works by Christoph Varenhorst

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

scientific article published in December 2017

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

scientific article published in January 2018

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

scientific article published on 26 August 2017

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

scientific article published on 26 August 2017

Assessment of P2Y(12) inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin

scientific article published on 6 February 2009

Causes of mortality with ticagrelor compared with clopidogrel in acute coronary syndromes

scientific article published on 23 June 2014

Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease

scientific article published on 09 January 2014

Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)

scientific article published on 28 August 2015

Duration of dual antiplatelet treatment with clopidogrel and aspirin in patients with acute coronary syndrome.

scientific article

Effect of genetic variations on ticagrelor plasma levels and clinical outcomes

scientific article published on 2 May 2015

Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways

scientific article published on 05 September 2013

Factors Contributing to the Lower Mortality With Ticagrelor Compared With Clopidogrel in Patients Undergoing Coronary Artery Bypass Surgery

article

Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease

scientific article published on 09 May 2009

Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndrome

scientific article

Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease

scientific article published on 01 October 2008

Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study

scientific article

NLRC4 Inflammasome Is an Important Regulator of Interleukin-18 Levels in Patients With Acute Coronary Syndromes: Genome-Wide Association Study in the PLATelet inhibition and patient Outcomes Trial (PLATO).

scientific article published on 6 March 2015

Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry

scientific article published on 19 July 2016

Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivo

scientific article

Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease

scientific article published on 30 November 2007

Relationship Between Early and Late Nonsustained Ventricular Tachycardia and Cardiovascular Death in Patients With Acute Coronary Syndrome in the Platelet Inhibition and Patient Outcomes (PLATO) Trial

scientific article published on February 2016

Relationship between clopidogrel-induced platelet P2Y12 inhibition and stent thrombosis or myocardial infarction after percutaneous coronary intervention-a case-control study

scientific article published on 20 July 2011

Sex as a determinant of prehospital ECG in ST- and non-ST elevation myocardial infarction patients.

scientific article published on 24 July 2014

Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI: a report from SCAAR.

scientific article published in July 2014

Stent thrombosis rates the first year and beyond with new- and old-generation drug-eluting stents compared to bare metal stents.

scientific article published on 17 April 2018

Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial

scientific article

Treatment patterns and outcomes in patients undergoing percutaneous coronary intervention treated with prasugrel or clopidogrel (from the Swedish Coronary Angiography and Angioplasty Registry [SCAAR]).

scientific article

Which antiplatelet agent for whom? Which patient populations benefit most from novel antiplatelet agents (ticagrelor, prasugrel)?

scientific article published on August 2012

Paulina is supported by:

About Paulina

Help